Prebiotic Treatment in People With Schizophrenia

被引:1
作者
Buchanan, Robert W. [1 ]
Werkheiser, Anne E. [2 ]
Michel, Hanna [1 ]
Zaranski, Jennifer [1 ]
Glassman, Matthew [1 ]
Adams, Heather A. [1 ]
Vyas, Gopal [1 ]
Blatt, Frank [1 ]
Pilli, Nageswara R. [3 ]
Pan, Yezhi [1 ]
Chen, Shuo [1 ]
Fraser, Claire M. [4 ]
Kelly, Deanna L. [1 ]
Kane, Maureen A. [4 ]
机构
[1] Univ Maryland, Maryland Psychiat Res Ctr, Sch Med, Dept Psychiat, Baltimore, MD USA
[2] Georgia State Univ, Dept Psychol, Atlanta, GA USA
[3] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD USA
[4] Univ Maryland, Inst Genom Sci, Sch Med, Baltimore, MD USA
关键词
butyrate; gut-brain axis; microbiota; prebiotic; schizophrenia; BUTYRATE; MICROBIOTA; DIVERSITY; STRESS;
D O I
10.1097/JCP.0000000000001899
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
BackgroundPreliminary evidence suggests that people with schizophrenia have decreased relative abundance of butyrate-producing bacteria in the gut microbiota. Butyrate plays a critical role in maintaining the integrity of the gut-blood barrier and has a number of anti-inflammatory effects. This proof-of-concept study was designed to assess whether the addition of the oligofructose-enriched inulin (OEI) prebiotic: Prebiotin could increase the production of butyrate.MethodsTwenty-seven people who met the criteria for either Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, schizophrenia or schizoaffective disorder were entered into a 10-day, double-blind, placebo-controlled, randomized clinical trial. The study was conducted on an inpatient unit to standardize the participant diet and environment. Participants were randomized to either OEI (4 g, 3 times a day) or a placebo (4 g of maltodextrin, 3 times a day). In order to assess the effect of OEI treatment on butyrate levels, participants underwent pretreatment and posttreatment OEI challenges. The primary outcome measure was relative change in postchallenge plasma butyrate levels after 10 days of OEI treatment.ResultsIn both the intent-to-treat and completer analyses, OEI treatment was associated with a greater number of participants who met the OEI challenge responder criteria than those treated with placebo. OEI treatment was also associated with an increase in baseline butyrate levels (effect size for the group difference in the change of baseline butyrate levels was 0.58).ConclusionsWe were able to demonstrate that treatment with the prebiotic OEI selectively increased the level of plasma butyrate in people with schizophrenia.Trial registration: ClinicalTrials.gov identifier NCT03617783ConclusionsWe were able to demonstrate that treatment with the prebiotic OEI selectively increased the level of plasma butyrate in people with schizophrenia.Trial registration: ClinicalTrials.gov identifier NCT03617783
引用
收藏
页码:457 / 461
页数:5
相关论文
共 31 条
  • [1] American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, V5th
  • [2] Role of the gut microbiome in three major psychiatric disorders
    Borkent, Jenny
    Ioannou, Magdalini
    Laman, Jon D.
    Haarman, Bartholomeus C. M.
    Sommer, Iris E. C.
    [J]. PSYCHOLOGICAL MEDICINE, 2022, 52 (07) : 1222 - 1242
  • [3] Is butyrate the link between diet, intestinal microbiota and obesity-related metabolic diseases?
    Brahe, L. K.
    Astrup, A.
    Larsen, L. H.
    [J]. OBESITY REVIEWS, 2013, 14 (12) : 950 - 959
  • [4] THE MICROBIOTA-GUT-BRAIN AXIS
    Cryan, John F.
    O'Riordan, Kenneth J.
    Cowan, Caitlin S. M.
    Sandhu, Kiran V.
    Bastiaanssen, Thomaz F. S.
    Boehme, Marcus
    Codagnone, Martin G.
    Cussotto, Sofia
    Fulling, Christine
    Golubeva, Anna V.
    Guzzetta, Katherine E.
    Jaggar, Minal
    Long-Smith, Caitriona M.
    Lyte, Joshua M.
    Martin, Jason A.
    Molinero-Perez, Alicia
    Moloney, Gerard
    Morelli, Emanuela
    Morillas, Enrique
    O'Connor, Rory
    Cruz-Pereira, Joana S.
    Peterson, Veronica L.
    Rea, Kieran
    Ritz, Nathaniel L.
    Sherwin, Eoin
    Spichak, Simon
    Teichman, Emily M.
    van de Wouw, Marcel
    Ventura-Silva, Ana Paula
    Wallace-Fitzsimons, Shauna E.
    Hyland, Niall
    Clarke, Gerard
    Dinan, Timothy G.
    [J]. PHYSIOLOGICAL REVIEWS, 2019, 99 (04) : 1877 - 2013
  • [5] DeRenzo E G, 1998, J Health Care Law Policy, V1, P66
  • [6] Genomics of schizophrenia: time to consider the gut microbiome?
    Dinan, T. G.
    Borre, Y. E.
    Cryan, J. F.
    [J]. MOLECULAR PSYCHIATRY, 2014, 19 (12) : 1252 - 1257
  • [7] Collective unconscious: How gut microbes shape human behavior
    Dinan, Timothy G.
    Stilling, Roman M.
    Stanton, Catherine
    Cryan, John F.
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 63 : 1 - 9
  • [8] First M.B., 2015, Structured clinical interview for DSM-5Research version (SCID-5 for DSM-5, research version
  • [9] SCID-5-RV), DOI DOI 10.1002/9781118625392.WBECP351
  • [10] Dietary modulation of the human colonic microbiota: updating the concept of prebiotics
    Gibson, GR
    Probert, HM
    Van Loo, J
    Rastall, RA
    Roberfroid, MB
    [J]. NUTRITION RESEARCH REVIEWS, 2004, 17 (02) : 259 - 275